Evogene (EVGN) FCF Margin Growth (5y) (2018 - 2026)
Evogene (EVGN) FCF Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Evogene | 4.38 Mn | 4.38 Mn | 204,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,932.00 |
| Dec 31, 2025 | -284,040.00 |
| Sep 30, 2025 | -148,184.00 |
| Jun 30, 2025 | 62,806.00 |
| Mar 31, 2025 | 669,733.00 |
| Dec 31, 2024 | -394,197.00 |
| Sep 30, 2024 | -435,287.00 |
| Jun 30, 2024 | 301,324.00 |
| Mar 31, 2024 | 161,726.00 |
| Dec 31, 2023 | 145,572.00 |
| Sep 30, 2023 | 93,988.00 |
| Jun 30, 2023 | 13,577.00 |
| Mar 31, 2023 | 231,259.00 |
| Dec 31, 2022 | 13,387.00 |
| Sep 30, 2022 | -103,152.00 |
| Jun 30, 2022 | -169,623.00 |
| Mar 31, 2022 | 371,270.00 |
| Dec 31, 2021 | -233,189.00 |
| Sep 30, 2021 | -353,961.00 |
| Jun 30, 2021 | 484,090.00 |